GlobeNewsWire
21 Sept 2026, 11:50 UTC · 1h ago
Verdict
Headline leans bearish. We score HIMS −1.00 across three claims.
Score confirms the headline.
Leans bearish
From its wording — no explicit rating
−1.00strongly bearish
What the story claims
3 claims · scored −1 bearish … +1 bullish · 2 new · 1 priced in
The FTC filed a lawsuit against Hims & Hers on July 29, 2026, alleging the company shared sensitive health data with platforms like Meta and Snap and deceived users regarding billing.
Priced inevent occurred July 29, 2026
So whatThe resulting 15% share price drop indicates an immediate hit to market cap, but pending FTC penalties could further compress margins in FY2027.
More negative than 94% of claims this week
Continue reading
5 related stories
More negative than 96% of ticker scores this week
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
Robbins Geller Rudman & Dowd LLP announced on September 21, 2026, a class action lawsuit seeking lead plaintiffs for securities purchased between August 4, 2025 and July 29, 2026.
Newannounced Sept 21, 2026
More negative than 77% of claims this week
Investors have until November 2, 2026, to seek appointment as lead plaintiff in the Hims & Hers securities fraud lawsuit.
Newannounced Sept 21, 2026
So whatThis deadline establishes the timeline for the initial phase of litigation, with lead plaintiff selection likely concluding by late Q4 2026.
More negative than 66% of claims this week
Which stocks this story touches
More negative than 96% of ticker scores this week
The company is facing a class action lawsuit and FTC action alleging deceptive billing and privacy violations, leading to a 15% share price drop.
More negative than 75% of ticker scores this week
Mentioned as a third-party platform that received sensitive health information from Hims & Hers, linking it to a regulatory controversy.
More negative than 75% of ticker scores this week
Mentioned as a third-party platform that received sensitive health information from Hims & Hers, linking it to a regulatory controversy.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
3h ago
More positive than 18% of relationship scores this week
[a_to_b] Hims & Hers shared consumer health information with Snap's advertising platform.
—
HIMS hasn't traded since this ran. Last close $27.99 (Sep 18); the reaction starts at the next open.
HIMS chart →
